Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-004846
Filing Date
2025-04-15
Accepted
2025-04-15 16:57:03
Documents
81
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2070052
2 ex23-1.htm EX-23.1 2650
3 ex31-1.htm EX-31.1 9878
4 ex31-2.htm EX-31.2 9802
5 ex32-1.htm EX-32.1 3571
6 ex32-2.htm EX-32.2 3684
  Complete submission text file 0001641172-25-004846.txt   8982388

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE otlc-20241231.xsd EX-101.SCH 65623
8 XBRL CALCULATION FILE otlc-20241231_cal.xml EX-101.CAL 55158
9 XBRL DEFINITION FILE otlc-20241231_def.xml EX-101.DEF 332019
10 XBRL LABEL FILE otlc-20241231_lab.xml EX-101.LAB 520094
11 XBRL PRESENTATION FILE otlc-20241231_pre.xml EX-101.PRE 447346
83 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1244022
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

EIN.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 25840250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)